Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-26-004165
Filing Date
2026-02-13
Accepted
2026-02-13 17:01:12
Documents
1
Period of Report
2026-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3726
  Complete submission text file 0001437749-26-004165.txt   5451
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Issuer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AURA BIOSCIENCES, INC. 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address
De Rosch Mark (Reporting) CIK: 0001890320 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37942 | Film No.: 26634305